BSE Live
Apr 10, 16:01Prev. Close
25.04
Open Price
25.74
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Panjon (in Rs. Cr.) | Mar 05 | Mar 04 | |
| 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | |||
| SHAREHOLDER'S FUNDS | |||
| Equity Share Capital | 10.48 | 9.98 | |
| Total Share Capital | 10.48 | 9.98 | |
| Reserves and Surplus | 3.57 | 3.45 | |
| Total Reserves and Surplus | 3.57 | 3.45 | |
| Total Shareholders Funds | 14.05 | 13.43 | |
| NON-CURRENT LIABILITIES | |||
| Long Term Borrowings | 3.28 | 4.22 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 3.28 | 4.22 | |
| CURRENT LIABILITIES | |||
| Short Term Borrowings | 0.00 | 0.00 | |
| Trade Payables | 0.00 | 0.00 | |
| Other Current Liabilities | 4.48 | 2.58 | |
| Short Term Provisions | 0.08 | 0.12 | |
| Total Current Liabilities | 4.56 | 2.70 | |
| Total Capital And Liabilities | 21.89 | 20.35 | |
| ASSETS | |||
| NON-CURRENT ASSETS | |||
| Tangible Assets | 7.38 | 7.55 | |
| Intangible Assets | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.02 | 0.00 | |
| Other Assets | 0.00 | 0.00 | |
| Fixed Assets | 7.40 | 7.55 | |
| Non-Current Investments | 1.18 | 1.18 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | |
| Total Non-Current Assets | 8.58 | 8.73 | |
| CURRENT ASSETS | |||
| Current Investments | 0.00 | 0.00 | |
| Inventories | 3.55 | 3.36 | |
| Trade Receivables | 5.46 | 4.92 | |
| Cash And Cash Equivalents | 0.30 | 0.04 | |
| Short Term Loans And Advances | 4.00 | 3.30 | |
| OtherCurrentAssets | 0.00 | 0.00 | |
| Total Current Assets | 13.31 | 11.62 | |
| Total Assets | 21.89 | 20.35 | |
| OTHER ADDITIONAL INFORMATION | |||
| CONTINGENT LIABILITIES, COMMITMENTS | |||
| Contingent Liabilities | 0.15 | 0.00 | |
| CIF VALUE OF IMPORTS | |||
| Raw Materials | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | |||
| Expenditure In Foreign Currency | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | |||
| Dividend Remittance In Foreign Currency | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | |||
| FOB Value Of Goods | -- | -- | |
| Other Earnings | -- | -- | |
| BONUS DETAILS | |||
| Bonus Equity Share Capital | -- | -- | |
| NON-CURRENT INVESTMENTS | |||
| Non-Current Investments Quoted Market Value | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | |
| CURRENT INVESTMENTS | |||
| Current Investments Quoted Market Value | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- |
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
04.03.2026
Panjon Standalone December 2025 Net Sales at Rs 14.14 crore, up 26.74% Y-o-Y
25.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
14.11.2025
Panjon Standalone September 2025 Net Sales at Rs 14.95 crore, up 342.44% Y-o-Y
21.08.2025
Panjon Standalone June 2025 Net Sales at Rs 6.42 crore, up 206.63% Y-o-Y
13.04.2026
10.04.2026
09.04.2026
08.04.2026
Indian CDMOs face tariff exposure via patented drug supply chains
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth